The Promise of Chimeric Antigen Receptor T-Cell Therapy.
Explore this paper's citation graph
Summary
Durable responses have been observed in patients who had not undergone consolidative stem cell transplant, a finding that correlates with reports of T-cell persistence and B-cell aplasia in studies of anti-CD19 treatment in vivo.
- Type
- article
- Published
- 2016-10-15
- Cited by
- 27
- References
- 0
- OpenAlex
- https://openalex.org/W2538566824
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34033806
Keywords
Chimeric antigen receptor, Cytokine release syndrome, CD19, Immunotherapy, Antigen
References
No references recorded for this paper.
Cited by
- Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies
- Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia
- New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV.
- Chimeric antigen receptor T-cell therapy for glioblastoma.
- Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells.
- Chimeric Antigen Receptor (CAR) T-Cell Therapy.
- Cancer Immunotherapy with Chimeric Antigen Receptor (CAR) T Cells
- Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
- Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy
- The Pharmacology of T Cell Therapies
- Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
- Genetically enhanced T lymphocytes and the intensive care unit
- Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy.
- Recent Progress in Gene Therapy for Ovarian Cancer
- Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.
- Az adoptív sejttranszfer sikere a hematológiában: a kiméra antigénreceptorral felruházott T-sejtek
- Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy.
- Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy
- Targeting cancer cells: from historic methods to modern chimeric antigen receptor (CAR) T-Cell strategies
- Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
Related papers
- Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy
- CAR Therapy for CLL: What are the Challenges?
- Treatment of aggressive lymphomas with anti-CD19 CAR T cells
- A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
- Unleash the power of the mighty T cells-basis of adoptive cellular therapy.
- Improving Therapy of Chronic Lymphocytic Leukemia (CLL) with Chimeric Antigen Receptor (CAR) T Cells
- A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
- Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy
- Cellular Immunotherapy in B-Cell Malignancy